Dermata Therapeutics Inc.

NASDAQ: DRMA · Real-Time Price · USD
5.90
0.09 (1.55%)
At close: Aug 15, 2025, 12:52 PM

Dermata Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-12.29M -7.79M -9.61M -7.9M
Depreciation & Amortization
n/a n/a n/a 14.13K
Stock-Based Compensation
657.65K 522.08K 930.33K 1.91M
Other Working Capital
575.38K 494.35K -135.03K -121.42K
Other Non-Cash Items
n/a n/a n/a n/a
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
466.86K 863.68K -153.58K 289.55K
Operating Cash Flow
-11.16M -6.41M -8.83M -5.69M
Capital Expenditures
n/a n/a 4.00 n/a
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a
Investing Cash Flow
n/a n/a n/a n/a
Debt Repayment
n/a n/a n/a 1.01M
Common Stock Repurchased
-828 -40 n/a -1M
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
1.11K 187.00 287.00 n/a
Financial Cash Flow
6.89M 7.61M 4.28M 15.96M
Net Cash Flow
-4.28M 1.2M -4.56M 10.27M
Free Cash Flow
-11.16M -6.41M -8.83M -5.69M